Loading stock data…
Thermo Fisher Scientific Inc (TMO)
$602.65-0.36 (-0.06%)
Market OpenUpdated 10:17 AM EDT
Thermo Fisher Scientific Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Thermo Fisher Scientific Inc. in the Healthcare sector is trading at $602.65 with a market capitalization of $232.5B. Wall Street consensus targets $638.11 (27 analysts), implying a +5.9% move over the next 12 months. The stock is currently 7% below its 52-week high of $647.00, remaining 12.5% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +5.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $11.99B↑ | $11.01B↓ | $12.21B↑ | $11.12B↑ | $10.85B |
| Gross Profit | $4.88B↑ | $4.43B↓ | $5.01B↑ | $4.58B↑ | $4.41B |
| Operating Income | $2.19B↑ | $1.91B↓ | $2.30B↑ | $2.08B↑ | $1.92B |
| Net Income | $1.74B↑ | $1.65B↓ | $1.96B↑ | $1.62B | $1.62B |
Peer Comparison
JNJUNHPFE
Fundamentals
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Inst...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$232.45B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
33.82
Beta
Defensive asset. Lower volatility than the S&P 500.
0.85
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.30%
ROE
Average efficiency. Growth may require heavy reinvestment.
13.23%
Volume
Today's trading volume
452,653
Recent News
Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls
Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Abercrombie & Fitch, Affirm Holdings, Eagle Materials, Klarna Group, Martin Marietta Materials, Oklo, Qualcomm, Robinhood Markets, Ulta Beauty, and More
Stocks took a beating Tuesday as surging oil prices and looming inflation data rattled every corner of the market, and now Wall Street analysts are reshuffling their calls on names ranging from nuclear energy upstart Oklo to retail giants Abercrombie and Ulta Beauty.
ILMN Stock Keeps Climbing. Should You Climb On?
A gene sequencing leader is on a powerful run fueled by real business quality, forcing investors to decide if the engine has more power than the price tag already reflects.
Should You Continue to Hold TMO Stock in Your Portfolio?
Thermo Fisher's growth is gaining momentum as acquisitions strengthen its life sciences reach, but macro risks and competition remain concerns.
‘Corporate America Is Basically Exterminating Your Career.” Clark Howard’s Sounds Alarm For Americans In Their 50s, Who Want To Work Till 65
Clark Howard named a specific age when corporate America tends to push workers out, and it falls years before most people's retirement plans even begin to account for income gaps, portfolio shortfalls, or Social Security decisions.